Jawed Fareed

21.7k citations
829 papers · 17.4k · 4 hit papers · h-index 54

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Hematology top 0.2%
    • Blood Coagulation and Thrombosis Mechanisms
    • Platelet Disorders and Treatments

Papers in

    • Blood Coagulation and Thrombosis Mechanisms 387
    • Platelet Disorders and Treatments 44
    • Venous Thromboembolism Diagnosis and Management 176

Jawed Fareed

792 papers receiving 16.3k citations

Jawed Fareed's Hit Papers

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial 2021 · 186 citations
1860+8+16Years since publication5001k1.5k2k

Peers

Jawed Fareed
Comparison fields: 5 of 158
  • Internal Medicine 3.5k
  • Hematology 4.3k
  • Biological Psychiatry 357
  • Infectious Diseases 2.3k
  • Cell Biology 1.3k
Replace Christoph Bode with:
Christoph Bode Germany
Oswald F Wagner Austria
Bernd Jilma Austria
Thomas L. Ortel United States
Emmanuel J. Favaloro Australia
Agneta G Siegbahn Sweden
Kenneth K. Wu United States
Andrew D. Blann United Kingdom
Kenneth Alan Bauer United States
Christian Josef Wiedermann Austria
Jawed Fareed relative to Christoph Bode Germany Christoph Bode's profile →
Citations per field
00.5×2×3×4×4.9×
Christoph Bode · 1×
Citations per year

Countries citing papers authored by Jawed Fareed

Since Specialization
Citations

This map shows the geographic impact of Jawed Fareed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jawed Fareed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jawed Fareed more than expected).

Fields of papers citing papers by Jawed Fareed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jawed Fareed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jawed Fareed. The network helps show where Jawed Fareed may publish in the future.

Co-authors

The 25 scholars most cited alongside Jawed Fareed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jawed Fareed Line = papers co-authored together Jawed Fareed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 829 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Hit paper breakdown →
20202275
2
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
Hit paper breakdown →
2001569
3 2006326
4
Prevention and treatment of venous thromboembolism - International Consensus Statement (Guidelines according to scientific evidence)
2006315
5 2011309
6 2013265
7
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
Hit paper breakdown →
2019257
8
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
1998216
9 2020205
10 1981198
11
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
Hit paper breakdown →
2021186
12
Prevention and treatment of venous thromboembolism--International Consensus Statement.
2013173
13 1992146
14 2003139
15 2018139
16 2020131
17 2009124
18
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
2001116
19 2000114
20 2002100

About Jawed Fareed

Jawed Fareed is a scholar working on Hematology, Internal Medicine, Surgery, Cell Biology and Immunology, having authored 829 papers that have together received 17.4k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (387 papers), Venous Thromboembolism Diagnosis and Management (176 papers), Heparin-Induced Thrombocytopenia and Thrombosis (115 papers), Proteoglycans and glycosaminoglycans research (64 papers), Platelet Disorders and Treatments (44 papers), Biosimilars and Bioanalytical Methods (32 papers), Sepsis Diagnosis and Treatment (25 papers) and Dialysis and Renal Disease Management (25 papers). The work is most often cited by research in Internal Medicine (3.5k citations), Hematology (4.3k citations), Biological Psychiatry (357 citations), Infectious Diseases (2.3k citations) and Cell Biology (1.3k citations). Jawed Fareed has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Debra Hoppensteadt, Jeanine M. Walenga, Walter P Jeske, Debra A. Hoppensteadt, Omer Iqbal, Rodger L. Bick, Harry L. Messmore, Robert J. Linhardt, Meyer Michel Samama and Bruce Lewis. Their work appears in journals such as Thrombosis Research, Blood, Seminars in Thrombosis and Hemostasis, Clinical and Applied Thrombosis/Hemostasis and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact